[1]
« Treatment of Psoriasiform Drug Eruptions in Patients on Immune Checkpoint Inhibitors », Can Dermatol Today, vol. 7, nᵒ 2, p. 14–18, juin 2026, doi: 10.58931/cdt.2026.72162.